Atlas Trials

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Clinical trial NCT07618078 · RECRUITING

Trial details

NCT number
NCT07618078
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Study type
OBSERVATIONAL
Nasopharyngeal Carcinoma (NPC)
Start date
2026-01-01
Primary completion
2031-12-31
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.